Mir-128 reduction in breast cancer tissues correlates chemotherapy resistance and poor patient survival. Mir-128 reduction in breast cancer tissues correlates.

Slides:



Advertisements
Similar presentations
Expression profiles for prognosis and prediction Laura J. Van ‘t Veer The Netherlands Cancer Institute, Amsterdam.
Advertisements

(+++) Normal breast ATM (++) IDC ATM Lymph node metastasis negative positive P-value A B X200 C Vector ATM - WT.
Prognostic Value of Genomic Analysis After Neoadjuvant Chemotherapy for Breast Cancer Mayer EL et al. Proc SABCS 2010;Abstract P
Potential Molecular Mechanisms for Improved Prognosis and Outcome with Neoadjuvant Chemotherapy Prior to Laparoscopical Radical Hysterectomy for Patients.
High-level TNFSF13 predict a good response to post-operative chemotherapy in patients with basal-like breast cancer: A systematic review 林惠鈺1,2 歸家豪1,3.
UHRF1 is regulated by miR-9 in colorectal cancer
25(OH)D and 1,25(OH)2D perfusion treatment effect on cancer-related markers: IF stains illustrating expression levels for Ki-67 (A), cyclin D1 (B), ErbB-2.
Kaplan–Meier curves for a, b) progression-free survival (PFS) and c, d) overall survival (OS) in a, c) large-cell neuroendocrine carcinoma patients and.
Treatment of human MCC tumors with intralesional IFNβ is associated with MHC-I upregulation. Treatment of human MCC tumors with intralesional IFNβ is associated.
B7-H4 expression correlates with MHC-I expression and improved prognosis in patients with breast cancer. B7-H4 expression correlates with MHC-I expression.
Serum miR-16: A Potential Biomarker for Predicting Melanoma Prognosis
Molecular Therapy - Nucleic Acids
Increase in beige/brown adipocyte characteristics in the xenografts from additional breast cancer cell lines. Increase in beige/brown adipocyte characteristics.
Fig. 7. NAC in breast cancer patients promotes TMEM assembly and increased MENAINV expression. NAC in breast cancer patients promotes TMEM assembly and.
HER-2/neu mRNA detection by gene expression profiling
Principal component analysis of adipose tissue fatty acids.
NICD1 immunohistochemical staining in normal and tumor tissue.
(A) Distribution of LATS2 mRNA expression levels in different breast cancer subtypes (PAM50, METABTIC dataset); ***P-value < 0.001, t test comparing lumB.
TFAP2A is highly expressed in nasopharyngeal carcinoma cells and tumor tissues. TFAP2A is highly expressed in nasopharyngeal carcinoma cells and tumor.
FAK overexpression in invasive human breast cancer and DCIS
Association between RB pathway alterations and poor prognosis in early-stage lung adenocarcinoma patients. Association between RB pathway alterations and.
Progastrin expression in colonic tissues and Kaplan–Meier survival curves. Progastrin expression in colonic tissues and Kaplan–Meier survival curves. A,
Protein expression profile in a dasatinib-resistant cell line.
LINC00092 binds with PFKFB2 to promote ovarian cancer metastasis.
Immune signatures of patients with short-, medium-, and long-term survival. Immune signatures of patients with short-, medium-, and long-term survival.
Overexpression of JMJD2B in clinical bladder cancers.
CD8, galectin-3, galectin-9, and the M1/M2 ratio are associated with a longer survival. CD8, galectin-3, galectin-9, and the M1/M2 ratio are associated.
Effect of nicotinamide and carbogen on 5-FU uptake (measured as SUV3
VEGF expression in neoplastic and normal prostate tissue.
IL-13Rα2 expression is associated to human colon cancer progression and poor survival of patients with colorectal cancer. IL-13Rα2 expression is associated.
A, RT-PCR expression of matriptase-1 and matriptase-2 in a variety of 24 human cell lines. A, RT-PCR expression of matriptase-1 and matriptase-2 in a variety.
EN1 expression in breast cancer and clinical outcome.
SAF-1 expression in clinical breast cancer tissues.
Somatic mutational rates and survival analysis of IBD-CRC.
ALDH1A3 expression levels are inversely correlated with the survival of patients with resectable mass-forming and advanced cholangiocarcinoma, respectively.
FILM immunohistochemical protein signature is significantly associated with poor survival. FILM immunohistochemical protein signature is significantly.
MRNA expression IL-1α, IL-1β, IL-1Ra, IL-1RtI, ER α, ER β, and PR was analyzed by RT-PCR as described in “Materials and Methods.” Representative gel electrographies.
Immunohistochemical analysis of dUTPase in human breast adenocarcinoma
Discovered and replicated positive correlation between miR-193b
Immunohistochemical staining of primary and metastatic prostatic carcinomas with anticyclin D1 and anti-Ki67 monoclonal antibodies. Immunohistochemical.
Expression of S100A11 in bulk pancreatic tissues (pancreatic cancer, n = 22; IPMN, n = 18; nonneoplastic pancreas, n = 22). Expression of S100A11 in bulk.
A protracted ketogenic diet increases radiation response in H292 lung cancer xenografts given conventional fractionated radiation. A protracted ketogenic.
Kaplan-Meier survival analysis of p53 mutation in the overall breast tumor series. Kaplan-Meier survival analysis of p53 mutation in the overall breast.
Nested RT-PCR of Mammaglobin and CK19 mRNA in plasma and circulating cells of controls (C) and patients (T) with breast cancer. Nested RT-PCR of Mammaglobin.
Coexpression of other immune genes with ImSig core signatures.
PD-L1 is expressed in breast cancer.
Immunohistochemical staining for FOXO3a of breast cancer tumor tissues
Reduced klotho expression in pancreatic cancer.
In situ analysis of human breast tissue shows the down-regulation of Spry isoforms in breast cancer. In situ analysis of human breast tissue shows the.
Correlations of the breast cancer hypoxia metagene with Ki67 and the proliferation metagene. Correlations of the breast cancer hypoxia metagene with Ki67.
MYC–HOXB7–HER2 predicts clinical outcome in breast cancer patients treated with tamoxifen. MYC–HOXB7–HER2 predicts clinical outcome in breast cancer patients.
Effect of CDV on human SF7796 xenografts in vivo.
Influence of ASGR2 expression on survival.
Kaplan–Meier curves for RFS and OS by various marker groups.
Association of overall survival and PAP-specific (A, B) and PA2024-specific (C, D) CTL activity at week 26 using categorical (tertile) analysis and continuous.
CD24 expression. CD24 expression. A, By global gene expression, CD24 is found to be highly upregulated in SEF (80×) and in LGFMS (37×) as compared with.
Enhanced expression of Cap43 gene by nickel in breast cancer cell lines. Enhanced expression of Cap43 gene by nickel in breast cancer cell lines. Expression.
Histology (H&E; original magnification, ×100 for B-2P/C-12P/C-64P and ×40 for C-10P; top) of small-sized lung adenocarcinomas and immunohistochemical staining.
Tumorigenicity of GR CAFs
Specific reaction with MIB1, M30, and CD31 monoclonal antibodies in primary human cervical carcinoma before (A, C, and E) and after (B, D, and F) Tam treatment.
A, TSG-6 staining in human prostate.
Inhibition of CD20 mRNA expression by ibrutinib correlates with reduced NF-κB activity. Inhibition of CD20 mRNA expression by ibrutinib correlates with.
Patient stratification using survival risk prediction and BCLC staging
A and B, linearity of the preamplification step shown by a similar expression pattern of ERα mRNA in four breast tumor samples pre– and post–linear amplification.
Regression analysis showing the positive correlation between number of months since the prior chemotherapy regimen (X axis) and the difference between.
A–J, Pretreatment (A) and post–cycle 3 (B) computed tomographic imaging for patient A–J, Pretreatment (A) and post–cycle 3 (B) computed tomographic.
Expression of TGFβ ligands in GBM
Immunohistochemical determination of TIM-3 expression in ccRCC.
Expression of the angiogenic phenotype in the 4-NQO mouse model of HNSCC. A, tissue sections containing areas of normal, hyperkeratosis, dysplasia, and.
GSN and DNMT1 expression are inversely correlated in a pattern associated with patient survival. GSN and DNMT1 expression are inversely correlated in a.
Presentation transcript:

Mir-128 reduction in breast cancer tissues correlates chemotherapy resistance and poor patient survival. Mir-128 reduction in breast cancer tissues correlates chemotherapy resistance and poor patient survival. MiR-128 expression was reduced in chemoresistant breast cancer tissues but upregulated in chemosensitive tissues, according to in situ hybridization (A) and real-time RT-PCR with a miR-128–specific primer amplifying both miR-128a and miR-128b (B, **, P < 0.001). A, representative pictures of immunohistochemical staining for Bmi-1 and ABCC5 in breast cancer tissues. Bmi-1 and ABCC5 expression was higher in chemoresistant than in chemosensitive breast tumor tissues. C, representative pictures of immunohistochemical staining for Ki67 (×200) and TUNEL staining (×200) in paired specimens of breast cancer obtained by core-needle biopsy prior to neoadjuvant chemotherapy and at surgery following chemotherapy. Breast tumors with low miR-128 expression showed stable Ki67 index and TUNEL index following chemotherapy, whereas those with high miR-128 showed a dramatically reduced Ki67 index and elevated TUNEL index after chemotherapy. D, Kaplan–Meier survival curves for breast cancer patients plotted against miR-128 expression show a statistical difference in survival between patients with high- and low-miR-128 expression (P < 0.05). Yinghua Zhu et al. Clin Cancer Res 2011;17:7105-7115 ©2011 by American Association for Cancer Research